A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Non-small Cell Lung Cancer|Melanoma|Brain Metastases
Interventions: DRUG: Abemaciclib
Sponsor: Eli Lilly and Company